Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1 — Yang Yang (2020) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1
Shared by
De Clercq Erik
KU Leuven
Privileged scaffold inspired design of novel oxime-biphenyl-DAPYs in treatment of HIV-1
Article
2020
en
Authors
+2 more
YY
Yang Yang
CP
Christophe Pannecouque
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs
Li Ding
,
Christophe Pannecouque
,
De Clercq Erik
,
Chunlin Zhuang
,
Fen‐Er Chen
Article
2020
Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
Tingting Li
,
Christophe Pannecouque
,
De Clercq Erik
,
Chunlin Zhuang
,
Fen‐Er Chen
Article
2015
A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities
Shuang‐Xi Gu
,
Heng Qiao
,
Yuan‐Yuan Zhu
,
Qi-Chao Shu
,
Hui Liu
,
Xiu-Lian Ju
,
De Clercq Erik
,
Jan Balzarini
,
Christophe Pannecouque
Article
2019
Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strains
Ya-Li Sang
,
Sheng Han
,
Shuwen Han
,
Christophe Pannecouque
,
De Clercq Erik
,
Chunlin Zhuang
,
Fen‐Er Chen
Article
2019
Improving the positional adaptability: structure-based design of biphenyl-substituted diaryltriazines as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
Kaijun Jin
,
Minjie Liu
,
Chunlin Zhuang
,
De Clercq Erik
,
Christophe Pannecouque
,
Ge Meng
,
Fen‐Er Chen
Discussion(0)
No comments yet. Be the first to comment.